Eculizumab er et humaniseret monoklonalt IgG2/ 4κ- antistof, der er produceret i en murin NS0- cellelinje ved rekombinant dna- teknologi.
Eculizumab is a humanised monoclonal IgG2/4 k antibody produced in NS0 cell line by recombinant DNA technology.